✦ LIBER ✦

W1096 Results from An Open-Label Extension of CHARM: Steroid-Free Remission in Patients with Crohn's Disease Who Received Adalimumab Therapy for At Least 3 Years

✍ Scribed by Kamm, Michael A.; Hanauer, Stephen B.; Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Lomax, Kathleen G.; Pollack, Paul F.

Book ID: 123313264
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 117 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)63010-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P083 - Steroid-free remission in patient

P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM

✍ M.A. Kamm; S.B. Hanauer; R. Panaccione; J.F. Colombel; W.J. Sandborn; K.G. Lomax 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 62 KB

S1056 Quality-of-Life Improvements in Pa

S1056 Quality-of-Life Improvements in Patients with Crohn's Disease Treated for 3 Years with Adalimumab in An Open-Label Extension of CHARM

✍ Edward V. Loftus; Jean-Frederic Colombel; Paul Rutgeerts; David T. Rubin; Naijun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

W1092 Maintenance of Long-Term Remission

W1092 Maintenance of Long-Term Remission in Patients with Moderately to Severely Active Crohn's Disease Treated for 3 Years with Adalimumab: Results from the Open-Label ADHERE Study

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB